# Zimmer Biomet Holdings, Inc.: filings

ZBH · NYSE · CIK 1136869 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/zbh.md) · [Financials](/companies/zbh/financials.md) · [Filings](/companies/zbh/filings.md) · [Insiders](/companies/zbh/insiders.md)

## Reports and events: 333 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1366, 8-K 229, 10-Q 53, 3 51, 425 48, SC 13G/A 37, 424B5 26, 144 22, DEFA14A 21, 10-K 18, DEF 14A 18, FWP 16, S-8 POS 16, SC 13G 15, UPLOAD 15, SD 13, ARS 11, CORRESP 9, S-8 9, 4/A 8, S-3ASR 7, SC 13D/A 7, SCHEDULE 13G/A 7, 424B7 6, SC TO-C 5, 11-K 4, SC 13D 4, 3/A 3, 8-A12B 3, SCHEDULE 13G 3, 8-K/A 2, CERT 2, DFAN14A 2, PRE 14A 2, SC TO-T/A 2, 10-Q/A 1, 25-NSE 1, 424B3 1, 5 1, CERTNYS 1, D 1, EFFECT 1, IRANNOTICE 1, S-4 1, S-4/A 1, SCHEDULE 13D 1, SC TO-T 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-08 | 20:30 ET | [8-K](/filings/0001193125-26-385256.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-385256 |
| 2026-08-05 | 20:11 ET | [8-K](/filings/0001193125-26-335108.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-335108 |
| 2026-08-05 | 20:06 ET | [10-Q](/filings/0001193125-26-335044.md) | Quarterly report, period 2026-06-30 | 0001193125-26-335044 |
| 2026-08-05 | 10:30 ET | [8-K](/filings/0001193125-26-333761.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-333761 |
| 2026-06-29 | 20:02 ET | [8-K](/filings/0001193125-26-288390.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-288390 |
| 2026-05-27 | 21:30 ET | [8-K](/filings/0001193125-26-242207.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-242207 |
| 2026-05-12 | 10:30 ET | [8-K](/filings/0001193125-26-218098.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-218098 |
| 2026-05-01 | 21:11 ET | [10-Q](/filings/0001193125-26-201710.md) | Quarterly report, period 2026-03-31 | 0001193125-26-201710 |
| 2026-04-28 | 10:33 ET | [8-K](/filings/0001193125-26-183430.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-183430 |
| 2026-04-28 | 10:30 ET | [8-K](/filings/0001193125-26-183411.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-183411 |
| 2026-04-01 | 11:00 ET | [DEF 14A](/filings/0001193125-26-135661.md) | Proxy statement, period 2026-05-22 | 0001193125-26-135661 |
| 2026-02-20 | 23:36 ET | [10-K](/filings/0001193125-26-059853.md) | Annual report, period 2025-12-31 | 0001193125-26-059853 |
| 2026-02-10 | 11:30 ET | [8-K](/filings/0001193125-26-043620.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-043620 |
| 2026-01-12 | 14:00 ET | [8-K](/filings/0001193125-26-009895.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-009895 |
| 2025-11-05 | 21:06 ET | [10-Q](/filings/0001193125-25-266884.md) | Quarterly report, period 2025-09-30 | 0001193125-25-266884 |
| 2025-11-05 | 11:30 ET | [8-K](/filings/0001193125-25-265649.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-265649 |
| 2025-10-07 | 20:10 ET | [8-K](/filings/0001193125-25-233473.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-233473 |
| 2025-09-04 | 20:15 ET | [8-K](/filings/0001193125-25-196060.md) | 8.01 Other events | 0001193125-25-196060 |
| 2025-08-07 | 20:06 ET | [10-Q](/filings/0000950170-25-104989.md) | Quarterly report, period 2025-06-30 | 0000950170-25-104989 |
| 2025-08-07 | 10:30 ET | [8-K](/filings/0000950170-25-104527.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104527 |
| 2025-07-15 | 20:57 ET | [SCHEDULE 13D](/filings/0000950170-25-095910.md) | Ownership report, active investor | 0000950170-25-095910 |
| 2025-07-14 | 11:40 ET | [8-K](/filings/0001193125-25-158442.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-158442 |
| 2025-06-30 | 20:15 ET | [8-K](/filings/0001193125-25-152694.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-152694 |
| 2025-06-03 | 11:30 ET | [8-K](/filings/0000950170-25-080567.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-080567 |
| 2025-05-27 | 11:35 ET | [8-K](/filings/0001193125-25-126231.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-126231 |
| 2025-05-05 | 20:00 ET | [10-Q](/filings/0000950170-25-063509.md) | Quarterly report, period 2025-03-31 | 0000950170-25-063509 |
| 2025-05-05 | 10:30 ET | [8-K](/filings/0000950170-25-063124.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-063124 |
| 2025-04-21 | 20:05 ET | [8-K](/filings/0001193125-25-087219.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-087219 |
| 2025-04-14 | 11:00 ET | [DEF 14A](/filings/0000950170-25-053494.md) | Proxy statement, period 2025-04-09 | 0000950170-25-053494 |
| 2025-02-25 | 21:14 ET | [8-K](/filings/0001193125-25-035147.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-035147 |
| 2025-02-25 | 21:01 ET | [10-K](/filings/0000950170-25-026604.md) | Annual report, period 2024-12-31 | 0000950170-25-026604 |
| 2025-02-19 | 21:16 ET | [8-K](/filings/0001193125-25-029614.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-029614 |
| 2025-02-18 | 21:17 ET | [8-K](/filings/0001193125-25-028618.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-028618 |
| 2025-02-06 | 11:30 ET | [8-K](/filings/0000950170-25-014972.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-014972 |
| 2025-01-29 | 11:34 ET | [8-K](/filings/0001193125-25-014881.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-014881 |
| 2025-01-29 | 23:33 ET | [8-K](/filings/0001193125-25-014569.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-014569 |
| 2024-11-20 | 21:10 ET | [8-K](/filings/0001193125-24-262540.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-262540 |
| 2024-11-19 | 21:15 ET | [8-K](/filings/0001193125-24-261733.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-261733 |
| 2024-10-30 | 20:05 ET | [10-Q](/filings/0000950170-24-118959.md) | Quarterly report, period 2024-09-30 | 0000950170-24-118959 |
| 2024-10-30 | 10:30 ET | [8-K](/filings/0000950170-24-118573.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-118573 |
| 2024-08-15 | 20:16 ET | [8-K](/filings/0001193125-24-201328.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-201328 |
| 2024-08-14 | 20:16 ET | [8-K](/filings/0001193125-24-200634.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-24-200634 |
| 2024-08-07 | 21:17 ET | [8-K](/filings/0000950170-24-092996.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-092996 |
| 2024-08-07 | 20:05 ET | [10-Q](/filings/0000950170-24-092746.md) | Quarterly report, period 2024-06-30 | 0000950170-24-092746 |
| 2024-08-07 | 10:30 ET | [8-K](/filings/0000950170-24-092253.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-092253 |
| 2024-07-01 | 20:17 ET | [8-K](/filings/0001193125-24-173303.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-173303 |
| 2024-06-20 | 11:30 ET | [8-K](/filings/0000950170-24-075310.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-075310 |
| 2024-05-15 | 21:05 ET | [8-K](/filings/0000950170-24-060580.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-060580 |
| 2024-05-02 | 20:08 ET | [10-Q](/filings/0000950170-24-052097.md) | Quarterly report, period 2024-03-31 | 0000950170-24-052097 |
| 2024-05-02 | 10:30 ET | [8-K](/filings/0000950170-24-051551.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-051551 |

Page 1 of 7. [Older](/companies/zbh/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. No prices; not investment advice.